Antibodies for allergy and complement disease
Total Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
1,046
NCT05156333
Probiotics and GBS Colonization in Pregnancy
Phase: N/A
Role: Collaborator
Start: Oct 15, 2020
Completion: Dec 31, 2022
NCT06294288
A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 1, 2021
Completion: Mar 15, 2024
NCT06294275
A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects
Start: Sep 16, 2022
Completion: Apr 6, 2024
NCT06046391
Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult
Phase: Phase 2
Start: Jul 6, 2023
Completion: Dec 30, 2024
NCT06294301
A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants
Start: Nov 19, 2023
Completion: Oct 30, 2024
NCT06228560
Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment
Start: Jan 25, 2024
Completion: Jan 30, 2025
NCT07212426
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.
Start: Nov 14, 2024
Completion: Mar 31, 2028
NCT06604949
A Study of Single Dose of LP-003 in Healthy Adult Subjects
Start: Nov 30, 2024
Completion: Dec 31, 2026
NCT07148557
A Study of Single Dose of LP-003 in Adolescent Subjects
Phase: Phase 1/2
Start: Aug 31, 2025
Completion: Sep 30, 2026
Loading map...